Literature DB >> 19617894

Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids.

Kanokkarn Phromnoi1, Supachai Yodkeeree, Songyot Anuchapreeda, Pornngarm Limtrakul.   

Abstract

AIM: Stromelysin 1 (matrix metalloproteinase 3; MMP-3) is an enzyme known to be involved in tumor invasion and metastasis. In this study, flavonoids from vegetables and fruits, such as quercetin, kaempferol, genistein, genistin, and daidzein, were tested for their ability to modulate the secretion and activity of MMP-3 in the MDA-MB-231 breast cancer cell line. In addition, we investigated the in vitro effects of flavonoids on MDA-MB-231 cell invasion.
METHODS: The toxic concentration range of flavonoids was evaluated using the MTT assay. The ability of MDA-MB-231 cells to invade was evaluated using a modified Boyden chamber system. The activity of MMP-3 was determined by casein zymography. The secretion of MMP-3 was evaluated using Western blotting, casein zymography and confirmed by ELISA.
RESULTS: Some putative flavonoids, ie, quercetin and kaempferol (flavonols), significantly inhibited the in vitro invasion of MDA-MB-231 cells in a concentration-dependent manner, with IC(50) values of 27 and 30 micromol/L, respectively. Quercetin and kaempferol also reduced MMP-3 activity in a dose-dependent manner, with IC(50) values in the range of 30 micromol/L and 45 micromol/L, respectively. None of the flavonoids had a significant effect on the secretion of MMP-3.
CONCLUSION: These data show that the flavonols quercetin and kaempferol have higher anti-invasion potency and higher MMP-3 inhibitory activity than isoflavones genistein, genistin and daidzein. In contrast, neither flavonols nor isoflavones have any effect on MMP-3 secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617894      PMCID: PMC4006680          DOI: 10.1038/aps.2009.107

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  42 in total

1.  Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.

Authors:  M Balduyck; F Zerimech; V Gouyer; R Lemaire; B Hemon; G Grard; C Thiebaut; V Lemaire; E Dacquembronne; T Duhem; A Lebrun; M J Dejonghe; G Huet
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

3.  Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines.

Authors:  Pia Heikkilä; Olli Teronen; Merja Moilanen; Yrjö T Konttinen; Roeland Hanemaaijer; Minna Laitinen; Päivi Maisi; Gabri van der Pluijm; John D Bartlett; Tuula Salo; Timo Sorsa
Journal:  Anticancer Drugs       Date:  2002-03       Impact factor: 2.248

4.  Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.

Authors:  S Caltagirone; C Rossi; A Poggi; F O Ranelletti; P G Natali; M Brunetti; F B Aiello; M Piantelli
Journal:  Int J Cancer       Date:  2000-08-15       Impact factor: 7.396

5.  Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1, and laminin-5 in experimentally induced dermatitis herpetiformis lesions.

Authors:  K Airola; T Reunala; S Salo; U K Saarialho-Kere
Journal:  J Invest Dermatol       Date:  1997-01       Impact factor: 8.551

6.  Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.

Authors:  Javier Mercapide; Ricardo Lopez De Cicco; Javier S Castresana; Andres J P Klein-Szanto
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

7.  Spontaneous metastasis in matrix metalloproteinase 3-deficient mice.

Authors:  Anna Juncker-Jensen; John Rømer; Caroline J Pennington; Leif R Lund; Kasper Almholt
Journal:  Mol Carcinog       Date:  2009-07       Impact factor: 4.784

8.  Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro.

Authors:  Pamela J Magee; Hugh McGlynn; Ian R Rowland
Journal:  Cancer Lett       Date:  2004-05-10       Impact factor: 8.679

9.  Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.

Authors:  Cheng-Wei Lin; Wen-Chi Hou; Shing-Chuan Shen; Shu-Hui Juan; Ching-Huai Ko; Ling-Mei Wang; Yen-Chou Chen
Journal:  Carcinogenesis       Date:  2008-07-14       Impact factor: 4.944

10.  Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.

Authors:  Supachai Yodkeeree; Wittaya Chaiwangyen; Spiridione Garbisa; Pornngarm Limtrakul
Journal:  J Nutr Biochem       Date:  2008-05-20       Impact factor: 6.048

View more
  17 in total

1.  Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.

Authors:  Aki Murakami; Chiharu Tabata; Rie Tabata; Hisaya Okuwa; Takashi Nakano
Journal:  Oncol Lett       Date:  2011-12-23       Impact factor: 2.967

2.  Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model.

Authors:  Wei Yang; Muneeb Ahmed; Beenish Tasawwar; Tatynana Levchenko; Rupa R Sawant; Vladimir Torchilin; S Nahum Goldberg
Journal:  J Control Release       Date:  2011-12-30       Impact factor: 9.776

3.  Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression.

Authors:  Mehrnaz Moradi; Hajar Gholipour; Houri Sepehri; Farnoosh Attari; Ladan Delphi; Ehsan Arefian; Mahdi Moridi Farimani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-07-02       Impact factor: 3.000

4.  Galangin and kaempferol suppress phorbol-12-myristate-13-acetate-induced matrix metalloproteinase-9 expression in human fibrosarcoma HT-1080 cells.

Authors:  Yu Jung Choi; Young Hun Lee; Seung-Taek Lee
Journal:  Mol Cells       Date:  2014-12-10       Impact factor: 5.034

Review 5.  A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention.

Authors:  Allen Y Chen; Yi Charlie Chen
Journal:  Food Chem       Date:  2012-12-28       Impact factor: 7.514

6.  Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  G Bobe; G Murphy; P S Albert; L B Sansbury; E Lanza; A Schatzkin; N H Colburn; A J Cross
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

7.  Arsenic-Induced Hepatic Toxicity and Its Attenuation by Fruit Extract of Emblica officinalis (Amla) in Mice.

Authors:  Manish K Singh; Shailendra Dwivedi; Suraj S Yadav; Praveen Sharma; Sanjay Khattri
Journal:  Indian J Clin Biochem       Date:  2013-06-15

8.  Kaempferol inhibits the growth and metastasis of cholangiocarcinoma in vitro and in vivo.

Authors:  Youyou Qin; Wu Cui; Xuewei Yang; Baifeng Tong
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-15       Impact factor: 3.848

9.  Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.

Authors:  Huiyan Li; Sébastien Bergeron; Matthew G Annis; Peter M Siegel; David Juncker
Journal:  Mol Cell Proteomics       Date:  2015-02-13       Impact factor: 5.911

10.  Kaempferol promotes apoptosis in human bladder cancer cells by inducing the tumor suppressor, PTEN.

Authors:  Feng Xie; Ming Su; Wei Qiu; Min Zhang; Zhongqiang Guo; Boxing Su; Jie Liu; Xuesong Li; Liqun Zhou
Journal:  Int J Mol Sci       Date:  2013-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.